Search

Displaying results 8681 - 8690 of 10000 in total
  1. Drug

    AZD-1236

    go.drugbank.com/drugs/DB11961
    Investigational

    AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

  2. Drug

    BMS-986094

    go.drugbank.com/drugs/DB11966
    Investigational

    INX-08189 has been used in trials studying the treatment of Hepatitis C, HCV (Genotype 1), and Hepatitis C Virus.

  3. Drug

    TAK-448

    go.drugbank.com/drugs/DB11975
    Investigational

    TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.

  4. Drug

    Elubrixin

    go.drugbank.com/drugs/DB12135
    Investigational

    Elubrixin has been used in trials studying the treatment of Cystic Fibrosis, Colitis, Ulcerative, and Chronic Obstructive Pulmonary Disease (COPD).

  5. Drug

    Exatecan

    go.drugbank.com/drugs/DB12185
    Investigational

    Exatecan has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Lung Cancer, and Liver Cancer, among others.

  6. Drug

    Aticaprant

    go.drugbank.com/drugs/DB12341
    Investigational

    Aticaprant has been used in trials studying the health services research and basic science of Anxiety Disorders and Alcohol Dependence.

  7. Drug

    Ensituximab

    go.drugbank.com/drugs/DB12342
    Investigational

    Ensituximab has been used in trials studying the treatment of Pancreatic Cancer, Adult, Metastatic Colorectal Cancer, and Metastatic Pancreatic Cancer.

  8. Drug

    Silatecan

    go.drugbank.com/drugs/DB12384
    Investigational

    Silatecan has been used in trials studying the treatment of GBM, Tumors, Gliosarcoma, Solid Malignancies, and Glioblastoma Multiforme, among others.

  9. Drug

    AZD3409

    go.drugbank.com/drugs/DB04893
    Experimental

    AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been disc...

  10. Drug

    Ulotaront

    go.drugbank.com/drugs/DB15665
    Investigational

    [L12891] An initial clinical study has shown this drug may be effective against both positive and negative symptoms of schizophrenia. … Unlike other drugs used for this condition, SEP-363856 does not bind to the dopamine D2 receptors, but exerts actions on the trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5